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a b s t r a c t
The highly active antiretroviral therapy reduces HIV-1 RNA in plasma to undetectable levels. However,
the virus continues to persist in the long-lived resting CD4þ T cells, macrophages and astrocytes which
form a viral reservoir in infected individuals. Reactivation of viral transcription is critical since the host
immune response in combination with antiretroviral therapy may eradicate the virus. Using the
chronically HIV-1 infected T lymphoblastoid and monocytic cell lines, primary quiescent CD4þ T cells
and humanized mice infected with dual-tropic HIV-1 89.6, we examined the effect of various X-ray
irradiation (IR) doses (used for HIV-related lymphoma treatment and lower doses) on HIV-1 transcrip-
tion and viability of infected cells. Treatment of both T cells and monocytes with IR, a well-deﬁned stress
signal, led to increase of HIV-1 transcription, as evidenced by the presence of RNA polymerase II and
reduction of HDAC1 and methyl transferase SUV39H1 on the HIV-1 promoter. This correlated with the
increased GFP signal and elevated level of intracellular HIV-1 RNA in the IR-treated quiescent CD4þ T
cells infected with GFP-encoding HIV-1. Exposition of latently HIV-1infected monocytes treated with PKC
agonist bryostatin 1 to IR enhanced transcription activation effect of this latency-reversing agent.
Increased HIV-1 replication after IR correlated with higher cell death: the level of phosphorylated Ser46
in p53, responsible for apoptosis induction, was markedly higher in the HIV-1 infected cells following IR
treatment. Exposure of HIV-1 infected humanized mice with undetectable viral RNA level to IR resulted
in a signiﬁcant increase of HIV-1 RNA in plasma, lung and brain tissues. Collectively, these data point to
the use of low to moderate dose of IR alone or in combination with HIV-1 transcription activators as a
potential application for the “Shock and Kill” strategy for latently HIV-1 infected cells.
& 2015 Elsevier Inc. All rights reserved.
Background
Besides productive infection in active CD4þ T lymphocytes and
macrophages, HIV-1 is capable of maintaining latent infection in
stable reservoirs such as resting CD4þ T cells, naïve T cells and
CD34þ multipotent hematopoietic stem cells (Carter et al., 2010;
Eisele and Siliciano, 2012; Wightman et al., 2010). HIV-1 can also
persist in such long-lived reservoirs as perivascular macrophages,
microglia and astrocytes, which together form the central nervous
system (CNS) tissue viral reservoir in infected individuals (Alexaki
et al., 2008; Churchill et al., 2009; Clements et al., 2011). The latent
infection reservoirs may persist for many years even though the
patients are usually treated with highly active antiretroviral
therapy (HAART). Thus, the virus can be activated rapidly once
HAART is stopped (Chun et al., 1999; Finzi et al., 1999; Richman
et al., 2009). Therefore, precise detection of the latently HIV-1
infected cells and elicitation of the treatment that can directly
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eliminate latently HIV-1 infected cells within the pool of resting T
cells and macrophages are important for effective depletion of the
viral reservoirs and eventual eradication of infection.
One of the major factors that determine HIV-1 latency, i.e.
silencing of integrated viral genome, is down regulation or
repression of HIV-1 transcription. Suppressed expression of Tat,
multiple transformations of a positive transcription elongation
factor b (P-TEFb) (Bisgrove et al., 2007; Chen et al., 2004;
Hargreaves et al., 2009; Yang et al., 2005), as well as such
epigenetic mechanisms as deacetylation of lysine residues in
LTR-bound histones by histone deacetylases (HDAC) (Tyagi et al.,
2010), methylation of histone H3 (Pearson et al., 2008) and direct
methylation of cytosine residues in two CpG islands ﬂanking HIV-1
transcription start site (Kauder et al., 2009) are critical factors of
the repression of LTR transcription (Furia et al., 2002; Williams
et al., 2007). Thus, the activation of latent HIV-1 proviral genomes
in the infected cells, that results in viral replication is critical, since
the virus itself as well as the host immune response in combina-
tion with antiretroviral drugs (“shock and kill” strategy) may
eliminate the virus following reactivation. Current approaches to
use pharmacologic induction of HIV-1 transcription for virus
reactivation are promising. However, recently performed testing
of such latency-reversing agents (LRAs) as HDAC inhibitors (vor-
inostat, romidepsin and panobinostat), NF-κB activator, disul-
ﬁram; and the bromodomain-containing protein 4 inhibitor JQ1
using ex vivo viral outgrowth assay (VOA) showed that none of the
tested LRAs induced outgrowth of HIV-1 from the latent reservoir
of patients on ART. Only the protein kinase C (PKC) modulator
bryostatin-1 caused signiﬁcantly increased transcription of HIV-1
genome in reactivated CD4þ T cells (Bullen et al., 2014). These data
suggest that for successful “shock and kill” virus eradication,
additional non-pharmacological approaches are required.
Ionizing irradiation (IR) is the well-known and effective stress
signal that induces DNA damage and activates cellular stress
response. The typical X-ray- and γ-IR-induced DNA lesions cause
double strand brakes (DSB) that can result in induction of up to
four independent repair pathways: homologous recombination,
non-homologous end joining, (NHEJ), alternative-NHEJ, and
single-strand annealing (reviewed in Curtin (2012)). X-ray IR stress
usually activates NHEJ machinery (Hartlerode and Scully, 2009),
which is associated with enhanced activity of many cellular factors
involved in transcription activation, such as NFκB (Aggarwal,
2004), Sp1 (Iwahori et al., 2008), HAT1 (Lebel et al., 2010) and
CBP/p300 whose activation has been shown to lead to SWI/SNF-
mediated chromatin remodeling (Agbottah et al., 2006; Ogiwara
et al., 2011; Van Duyne et al., 2011). For HIV-infected cells, both X-
ray and γ-IR have been shown to activate LTR-driven transcription
via the activation of NF-кB DNA binding (Faure et al., 1995; Smith
et al., 2001), and to induce cell death via chromatin DNA-damage
(Ogawa et al., 2003). Our earlier studies indicated that single dose
of γ-IR differently activated infected T cells and their parental
uninfected cell lines, with respect to the cell cycle and gene
expression (Clark et al., 2000). Other studies reported that the
X-ray-treated human colonic carcinoma cells could activate NF-
кB-mediated HIV-1 transcription in non-irradiated cells through
the secretion of cell activating cytokines (Faure, 1998) indicating
indirect effect of IR on HIV-1 infected cells.
In the present study, we examined effect of various X-ray doses
(starting from the doses which are equivalent to the typically used
for therapy of HIV-related lymphoma (Altschuler et al., 1989; Haas,
2009; Yukl et al., 2013) and lower) on HIV-1 replication and viability
of chronically and latently infected CD4þ T cells and monocytes. We
observed that treatment of both peripheral blood mononuclear cells
(PBMCs) and monocytes with different IR doses led to signiﬁcant
increase of HIV-1 transcription. Combination of IR with PKC agonist
bryostatin 1 resulted in enhancement of HIV-1 transcription in
monocytes as compared to individual treatments. Both chronically
HIV-1 infected T cell lines and latently infected resting CD4þ T
lymphocytes displayed elevated level of apoptosis in response to IR
that correlated with the increased level of Ser46 phosphorylation
on the p53 protein. Finally, exposure of HIV-1 infected NSG
humanized mice with undetected basal levels of viral replication
showed dramatic increase of HIV-1 RNA in plasma, lung and brain
tissues. Taken together, these data suggest that IR-induced cellular
stress activates HIV-1 expression and facilitates the apoptotic death
of infected T cells possibly via phosphorylation of p53 protein.
Results
X-ray irradiation activates HIV-1 transcription in chronically-infected
cell lines and peripheral blood mononuclear cells
In our earlier published study (Clark et al., 2000), we showed
that treatment of chronically HIV-1 infected T cell lines with γ-IR
resulted in activation of virus replication and apoptosis, whereas
the uninfected parental cells demonstrated repair with minimal to
no apoptosis. In the present study we tested the effect of either the
doses of X-ray IR typically used for HIV-related lymphoma treat-
ment (Altschuler et al., 1989; Haas, 2009; Yukl et al., 2013) or the
lower doses, non-pathogenic for uninfected cells, on the transcrip-
tion of HIV-1 provirus in chronically-infected T cell line and
promonocytes. We found that exposure of the T cell line to 5 Gy
dose of IR led to 2.5–3-fold increase of RT activity in the culture
media of the treated cells 24 h post-IR, suggesting that IR induced
the expression of the integrated HIV-1 genome and virion produc-
tion (Fig. 1A). The promonocytes displayed slower response with
IR consisting of two-fold increase of the RT activity 48 h post-IR.
The chronically infected U1 and especially ACH-2 cell lines
support basal level of HIV-1 transcription (Poli et al., 1989). ACH-2
produces the virions that potentially may reinfect the cells and,
therefore, induce super-infection. To bring our model to the latent
Fig. 1. IR activates viral transcription in chronically HIV-1 infected cell lines and primary CD4þ Tcells through the enhancement of LTR-driven transcription. (A) Chronically HIV-
1 infected T cell line ACH-2 and promonocytes U1 were exposed to 5 Gy X-ray irradiation (IR). Reverse transcriptase (RT) activity was measured in culture medium at indicated time
points. Results are shown as a mean of three independent measurements7SD. Asterisk indicates pr0.05. (B) Same cell lines were pretreated with ART cocktail (indinavir, tenofovir,
lamivudine/emitricitabine,10 mMof each) for 10 days, washed and then exposed to 5 Gy X-ray IR in a fresh culture medium. HIV-1 RNAwasmeasured in the cytoplasmic extracts at 24 h
post-IR by quantitative RT-PCR using gag-speciﬁc primers. Results are shown as a mean of three independent measurements7SD. Asterisk indicates pr0.01. (C) PBMCs isolated from
two healthy donors were infected with HIV-189.6 dual-tropic strain (10 ng p24/105 primary activated PBMCs), and then cultured for 45 days with IL-7 (added every 5 days) to place cells
into the resting phase. Then the cells were exposed to 5 Gy dose of IR. HIV-1 RNAwasmeasured in the cytoplasmic extracts at 72 h post-IR by quantitative RT-PCR using env-speciﬁc and
TAR-speciﬁc primers. The RNA count is shown as a percentage of maximal level of TAR RNA in the cell lysate. The results are shown as a mean of triplicate measurements7SD. Asterisk
indicates pr0.01. (D) Chromatin immunoprecipitation (ChIP) assay of the nuclear extracts from ACH-2 cells was performed with indicated antibodies at 24 h post-IR as described in
Materials and Methods. Speciﬁc DNA sequences in the immunoprecipitates were detected by PCR using primers speciﬁc for the HIV-1 LTR. E) The data of ChIP assay (panel D) were
quantiﬁed using ImageJ software. Results are presented as a fold change of grey values for the LTR DNA bands in each immunocomplex; the value of untreated control is shown as 1.
(F) IR does not affect surface presentation of CD4 and CXCR4 receptors in HIV-1 infected and uninfected cells. The uninfected (CEM) and chronically HIV-1 infected (ACH-2) T cells were
exposed to 5 Gy IR, and then analyzed by ﬂow cytometry with FITC-anti-human CD4 and PE-anti-human CXCR4 labeling performed 24 h post IR treatment.
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HIV-1 infected cells, we pre-incubated cells with the cocktail of
antiretrovirals (ART) containing both protease inhibitor (indinavir)
and mixture of RT inhibitors including tenofovir and lamivudine/
emtricitabine for 10 days. The HIV-1 RNA was not detected in the
culture media (data not shown), but the basic level of HIV-1
persisted on the level around 1–2 copies per cell (Fig. 1B). Exposure
of these cells to 5 Gy IR dose led to twofold increase of HIV-1
transcription in ACH-2 and threefold in U1 cells within ﬁrst 24 h.
Unlike the immortalized cell lines, the PBMCs isolated from
healthy donor, infected with HIV-1, treated with IL-7 and then
cultured for 45 days (to obtain quiescent cells) displayed 5–50 fold
increase of unspliced viral RNA 48 h after IR in the samples from
different donors (Fig. 1C, left panel). Interestingly, quantiﬁcation of
HIV-1 TAR RNA in the lysates of irradiated T cells revealed a similar
trend. However, the absolute count of TAR was approximately ﬁve-
fold higher than the count of unspliced HIV-1 RNA (Fig. 1C, right
panel). Taken together, these data indicate that IR reactivates
transcription of the inactive HIV-1 genome in primary blood
mononuclear cells. The abundance of TAR RNA in HIV-1 infected
cells, as well as detectable level of this small viral non-coding RNA
in the lysates of latently HIV-1 infected cells, was reported earlier
by us and other colleagues (Klase et al., 2009; Narayanan et al.,
2013; Ouellet et al., 2008, 2013; Yeung et al., 2009). Since the basic
transcription of short viral RNA fragments which include TAR
sequence does not require Tat activity (Kao et al., 1987), the
enhanced level of both TAR and coding HIV-1 RNA in the cells
exposed to IR suggests that IR itself activated both Tat-dependent
and independent transcription from the LTR promoter.
To elucidate activation effect of IR on the HIV-1 LTR-driven
transcription, we performed ChIP assays to test the occupancy of
factors including Pol II as well HDAC1 and SUV39H1 (both markers
of suppression) on the HIV-1 LTR promoter (du Chene et al., 2007;
He and Margolis, 2002). The data in Fig. 1D and E indicate that the
untreated ACH-2 cells contain both suppressive markers of tran-
scription, HDAC1 (deacetylase) and SUV39H1 (methyl transferase)
and do not have much Pol II associated with the LTR promoter.
Treatment of the cells with IR showed almost complete removal of
SUV39H1 from the HIV-1 promoter and decrease of HDAC1
binding when cells were treated with ALLN. Importantly, Pol II
binding displayed from 50 to 100-fold increase to the LTR
promoter (panel E).
Finally, to test whether IR can affect presentation of CD4
receptor as well as CXCR4 co-receptor on the surface of treated
cells and, therefore, potentially enhance or weaken reinfection of
the cells with the virus released after reactivation, we tested CD4
and CXCR4 in irradiated uninfected CEM and HIV-1 infected ACH-2
cells via ﬂow cytometry. Histogram plots in Fig. 1F indicate that IR
did not have detectable effect on the presentation of the receptors
important for HIV-1 entry on the surface of exposed cells.
Collectively, these data imply that activation effect of X-ray
treatment on HIV-1 transcription involves epigenetic mechanisms.
Exposure of HIV-1 infected T cells and monocytes treated with PKC
agonist bryostatin 1 to IR enhances the LRA activation effect on viral
transcription in latently infected monocytes
Bryostatin 1 is a potent PKC modulator. Recent studies have
shown that at low nanomolar concentrations bryostatin 1 dramati-
cally reactivated latent HIV-1 in monocytic and lymphocytic reser-
voirs via activation of PKCα and δ (Mehla et al., 2010). Since multiple
studies demonstrated effectiveness of bryostatin-1 for the reactiva-
tion of HIV-1 latency in different types of infected cells
(DeChristopher et al., 2012; Perez et al., 2010), we then tested
whether the exposure to IR enhanced bryostatin 1-induced activa-
tion of HIV-1 transcription. Bryostatin 1 has been shown to be
cytotoxic in the doses exceeding 10 nM (Bullen et al., 2014). Here we
tested effect of different IR doses on the ACH-2 and U1 cells, pre-
incubated with ART cocktail for 10 days, as described above, and
followed by treatment with three concentrations of bryostatin
(Fig. 2A). Quantitative analysis of unspliced HIV-1 RNA at 48 h
post-treatment with bryostatin 1 and 44 h after IR showed not
dramatic but signiﬁcant impact of bryostatin 1 on the enhancement
of HIV-1 transcription in ACH-2 cells. However, exposure of these
cells to IR did not contribute to the bryostatin 1 effect. In U1 cells, all
doses of bryostatin 1 drastically induced transcription of HIV-1 RNA.
Moreover, exposure to 1 and 3 Gy X-ray doses enhanced the
bryostatin 1 effect by 2.5–3 fold. The cell viability analysis demon-
strated that all bryostatin 1 doses tested indicated decreased
viability (Fig. 2B). Interestingly, while 3 Gy dose of IR slightly
reduced viability of bryostatin 1 untreated T cells, the viability of
the monocytes did not alter following irradiation. Analysis of
viability of parental uninfected (U-937) and chronically HIV-1
infected monocytes (U1) stimulated to differentiate into macro-
phages (Biswas et al., 1992; Poli et al., 1991), showed that after
treatment with various doses of IR the cell viability was not altered
among the various groups of cells (Fig. 2C). Both uninfected and HIV-
1 infected macrophage model cells showed no difference in viability
even when they were exposed to high single X-ray doses up to
20 Gy. In fact, macrophages may not be sensitive to IR, and when
radiotherapy is applied, the macrophages have been shown to be
radioresistant, survive and activated (Narang and Krishna, 2008).
Since HIV-1 genome in non-activated U1 cells displays very low
level of transcription and bryostatin 1 reactivates the virus from
“latent” stage, our data indicate that additional exposure to a
moderate (1 Gy) or higher doses of IR (Z1 Gy) may signiﬁcantly
increase reactivation effect of this PKC agonist on myeloid cells. In
ACH-2 the bryostatin 1 treatment enhanced transcription, but
additional effect of IR was not detected probably because of the
relatively high basic level of HIV-1 transcription in these cells.
X-ray IR activates HIV-1 replication and enhances apoptosis in
latently HIV-1 infected quiescent T cells
To test the effect of IR on the latently HIV-1 infected CD4þ T
cells, the cells were initially isolated from PBMCs, activated with
monocyte derived dendritic cells (MDDC) for four days and then
infected with full length, replication competent, CCR5-tropic HIV-
1 expressing GFP. Infection was expanded for two weeks and then
cells were placed in the medium containing IL-7 to achieve
quiescence and latency for an additional two weeks as described
earlier (Marini et al., 2008). After IR, the cells were cultured with
or without ALLN, harvested 96 h post-IR and then stained to
determine percentage of GFP positive (HIV-1 expressing) and
Annexin V positive (dying) cells. The ﬂow cytometry analysis of
remaining viable cells indicated that IR dose 5 Gy was cytotoxic,
since it decreased the population of quiescent CD4þ T cells
(Fig. 3A). IR led to 1.5-fold increase of the level of GFP expression.
Additional qPCR of total DNA from these cells did not reveal 2-LTR
circles within the samples (data not shown) that indicates the lack
of reinfection and expression of the viral genes only from provirus.
Indeed, IR had a profound effect on apoptosis induction and cell
survival. The percentage of Annexin V positive cells after IR was
twofold greater in the GFP-positive than in GFP-negative subsets
(Fig. 3A). It should be noted that basic level of apoptosis in GFP
positive cells was six fold higher, than in the negative control cells,
and that the absolute proportion of dying cells after IR is about
40% in the infected cell population and only 18.2% in uninfected
cells. Therefore cytopathogenic effect of IR on reactivated HIV-1
infected T cells is higher than on the uninfected cells.
Despite the higher cytopathogenicity of IR for HIV-1 infected
CD4þ T lymphocytes, the 20–30% cell death in the population of
uninfected CD4þT lymphocytes appeared high. To better deﬁne
S. Iordanskiy et al. / Virology 485 (2015) 1–154
the maximal dose of IR which is capable of reactivating HIV-1
transcription and does not activate apoptotic response in unin-
fected resting CD4þ T cells, we tested lower IR doses on the
apoptosis and HIV-1 RNA transcription in the cells. We found, that
doses r0.5 Gy did not dramatically increase apoptosis of the
uninfected cells (Fig. 3B), but increased level of HIV-1 transcription
(1.6 fold for 0.25 Gy dose of IR), in the infected cells (Fig. 3C),
suggesting that the doses between 0.25 and 0.5 Gy may be
considered as a potential reactivator of HIV-1 transcription in
resting CD4þ T cells.
IR activates p53 in both uninfected and chronically HIV-1 infected T
cells but enhances apoptotic pathways mostly in the infected cells
Our data above indicate that IR induces higher level of
apoptosis in HIV-1 infected primary cells, than in uninfected cells.
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Indeed, analysis of viability of PBMCs, infected or not with 89.6
strain of HIV-1, cultured for 45 days with IL-7 and then irradiated
with X-ray IR displayed four- to ﬁve-fold reduction in viability of
uninfected cells and 10-fold decrease viability of the infected cells
(Fig. 4A).
The cells respond to IR-induced genotoxic stress by activation
of DNA repair (reviewed in Curtin (2012)) and/or induction of
apoptosis in the case of severe DNA damage which cannot be
repaired by the Ataxia telangiectasia mutated (ATM)-induced DNA
damage repair pathways (Collis et al., 2004). Earlier studies
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
U
ns
pl
ic
ed
 H
IV
-1
 R
N
A
 
(fo
ld
 c
ha
ng
e)
IR (Gy): 0.250.1-
*
0 200 400 600 800 1000
FSC-H: FSC-Height
0
200
400
600
800
1000
-
-
3.95
0 200 400 600 800 1000
FSC-H: FSC-Height
0
200
400
600
800
1000
3.16
0 200 400 600 800 1000
FSC-H: FSC-Height
0
200
400
600
800
1000
0.089
Untreated 0.1 Gy 0.5 Gy
FL2-H: Annexin V PE
0
100
200
300
FL2-H: Annexin V PE
0
50
100
150
200
250
0
2
4
6
8
# 
C
el
ls
4.78 5.45 8.82
0 
G
y
0 200 400 600 800 1000
FSC-Height
0
200
400
600
800
1000
1.71
S
S
C
-H
R1
FL1-H: GFP
0
50
100
150
88.8 2.86
# 
ce
lls
0 200 400 600 800 1000
FSC-Height
0
200
400
600
800
1000
30.3
S
S
C
-H
R1
100 101 102 103 104
100 101 102 103 104
100 101 102 103 104 100 101 102 103 104
FL2-H: Annexin V PE
100 101 102 103 104
100 101 102 103 104 100 101 102 103 104
100 101 102 103 104 100 101 102 103 104
FL1-H: GFP
0
500
1000
1500
2000
2500
92.5 1.98
# 
ce
lls
R1
FL2-H: Annexin V PE
0
20
40
60
80
18.2# 
ce
lls
FL2-H: Annexin V PE
0
500
1000
1500
2.37
# 
ce
lls
FL2-H: Annexin V PE
0
0.5
1
1.5
2
2.5
40.1
# 
ce
lls
GFP-neg
FL2-H: Annexin V PE
0
10
20
30
14.0#
 c
el
ls
GFP -pos
5 
G
y
ApoptosisHIV -1 expressionR1- viable CD4+
T cells
H
ei
gh
t
S
S
C
: S
S
C
H -
- H
ei
gh
t
S
S
C
: S
S
C
H -
- H
ei
gh
t
S
S
C
: S
S
C
H
Fig. 3. IR activates HIV-1 replication and enhances apoptosis in latently infected primary quiescent CD4þ T cells. (A) Flow cytometry analysis of HIV-1 replication and
apoptosis in activated (memory-phenotype) primary CD4þ T cells enriched by negative selection from CD4þ T cells and monocyte-derived dendritic cell cultures and
infected with replication competent HIV-1 strain expressing GFP. The HIV-1 infected quiescent CD4þ T cells were treated with single 5 Gy X-ray IR dose, cultured for 96 h and
then subjected to ﬂow cytometry. Left panels show gating of live cells (R1) with numbers representing percent of total counts in plot (based on FSC-H vs. SSC-H). Other plots
represent analysis of R1 sub-population. The HIV-1 replication was measured as a percent of GFP-positive cells within the R1 population (second column of panels); the
percent of apoptotic cells was measured using Annexin V staining separately in subpopulations of GFP-negative and GFP-positive cells (right two columns of panels). (B) Flow
cytometry analysis of apoptosis in IR-treated uninfected primary CD4þ T cells (memory-phenotype) prepared as described in panel A. The cells were exposed to indicated
doses of IR and then analyzed at 48 h post-IR. The upper row indicates gating of living cells (R1) with numbers representing percent of total counts in plot (based on FSC-H vs
SSC-H). The bottom row shows the percent of apoptotic cells measured using Annexin V staining in the gated R1 sub-population. (C) The count of unspliced HIV-1 RNA in the
lysates of infected resting CD4þ T cells treated with indicated X-ray IR doses, measured by RT-qPCR with gag-speciﬁc primers 72 h after IR. Results are shown as a mean of
three independent measurements7SD. Asterisk indicates pr0.05 between indicated sample and unexposed (No IR) or 0.25 Gy IR exposed cells.
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Fig. 4. IR activates p53 in both uninfected and chronically HIV-1 infected T cells, but enhances apoptosis in the infected cells. (A) IR differentially induces apoptosis in
HIV-1 infected and uninfected PBMCs: the cells from two donors were infected or not with 89.6 dual-tropic strain of HIV-1, cultured for 45 days with IL-7, irradiated with
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experiments7SD. Asterisk indicates pr0.05 between indicated IR-exposed samples and non-irradiated cells. (B). Western blot analysis of p53 phosphorylation in the
lysates of parental uninfected (CEM) and chronically HIV-1 infected T cells (ACH-2) in response to X-ray IR (5 Gy). The cells were harvested 48 h after exposure, lysed in cell
lysis buffer containing proteasomal inhibitor cocktail (Roche). Lysates were then normalized according to the total protein concentration and subjected to SDS-PAGE and
Western blot analysis with rabbit polyclonal antibodies against total p53 and indicated phosphorylated forms of p53 protein. (C) Quantitation of Western blot bands. Western
blot bands were quantiﬁed using ImageJ software and results are presented as percentage of the peak value for each form of p53 protein (total or phosphorylated at Ser9,
Ser15 or Ser46) in analyzed cell lysates. (D) Western blot of lysates of HIV-1 chronically-infected (ACH-2) and parental uninfected (CEM) T cell lines treated with X-ray IR
(5 Gy). The cells were harvested at 48 h time point, lysed, normalized as described in panel B, and then subjected to SDS-PAGE and western blot analysis with rabbit
polyclonal antibodies against PARP-1 and mouse monoclonal antibodies against HIV-1 p24 and actin.
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indicated that low linear energy transfer IR, such as X-rays and γ-
rays, induce p53-dependent apoptosis in both normal and cancer
cells, whereas high linear energy transfer IR (α-particles) mostly
induce p53-independent apoptotic pathway (Haro et al., 2012;
Mori et al., 2009). For HIV-infected cells, both X-ray and γ-IR have
been shown to induce cell death via chromatin DNA-damage
(Ogawa et al., 2003). To test whether the enhanced apoptosis in
HIV-1 infected T cells is dependent on p53 activation, we analyzed
p53 phosphorylation at different sites critical for its activity to
induce the DNA repair pathways or apoptosis. Data in Fig. 4B
indicate phosphorylation of the Ser9 and Ser15 residues (both
trigger p53 activity to induce DNA repair pathways in response to
DNA damage (Haas, 2009; Oda et al., 2000; Shahbazi et al., 2013;
Xu et al., 2012; Yamaguchi et al., 2001)), as well as Ser46, whose
phosphorylation regulates the ability of p53 to induce apoptosis
(Oda et al., 2000). The western blot analysis showed that X-ray IR
induced phosphorylation of all analyzed serine residues in both
HIV-1 chronically infected and parental uninfected cells. However,
while the level of phosphorylation of Ser9 and Ser15 was the same
in both infected and uninfected cells, phosphorylation of Ser46
was approximately 40% higher in the infected T cells (Fig. 4C, top
panel). These data indicate that IR equally induced p53-mediated
DNA repair pathways in HIV-1 infected and uninfected cells, but
activated pro-apoptotic p53 activity predominantly in the
infected cells.
To further test this hypothesis, we performed western blot
analysis of the cellular factor PARP-1 involved in the DNA damage
induced apoptotic pathway. Both infected and uninfected cells
were X-ray irradiated. We found that the level of cleaved PARP-1
(indicator of apoptosis (Lazebnik et al., 1994)) was dramatically
higher in HIV-1 infected cells 48 h after IR, suggesting higher ratio
of DNA damage response in infected cells (Fig. 4D). Collectively,
these results imply that the HIV-1 chronically-infected cells are
more susceptible to DNA damage stress-induced apoptosis when
exposed to IR than uninfected cells.
Exposure to X-ray reactivates HIV-1 replication in various
tissues of infected humanized mice.
To test the effect of IR on viral replication in different tissues of
the infected animal, we used the model of NOD.Cg-Prkdcscid
IL2rgtm1Wjl/SzJ (NSG) humanized mice infected with dual-tropic
HIV-1 89.6 strain. Different colleagues (Choudhary et al., 2012;
Kassu et al., 2009; Marsden et al., 2012; Palmer et al., 2013), as
well as our group (Duyne et al., 2011) earlier showed that HIV-1-
infected BLT, hu-Rag2/ γ(c)/ and NSG mice can develop
latent infection – the virus is integrated, activation inducible, and
replication competent.
For analysis of IR on virus replication, we used mice that were
engrafted with human fetal liver derived CD34þ cells and infected
at 16 weeks after birth. We then waited for 6 months and then
irradiated with 4 Gy non-lethal X-ray dose (Guo et al., 2009; Wang
et al., 2013). The quantitative RT-PCR (qRT-PCR) analysis did not
reveal any HIV-1 RNA in the plasma samples before IR, whereas
qPCR detected various amounts of proviral DNA in the blood cells
from all infected animals (mice 1–6, Fig. 5A). The blood samples
obtained on day 10 after IR displayed from 2000 to 27,000 copies
of unspliced viral RNA per mg of total RNA (Fig. 5B). Analysis of the
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Fig. 5. IR activates HIV-1 transcription in various tissues of infected humanized mice. The NOD.Cg-Prkdcscid IL2rgtm1Wjl/SzJ (NSG) humanized mice were infected with
dual-tropic HIV-1 89.6 strain as described in Materials and Methods. The latent animals (6 months after initial infection) were irradiated with 4 Gy non-lethal X-ray dose and
sacriﬁced 10 days after IR. The blood, brain, liver, spleen and lung were harvested, homogenized and subjected to total RNA isolation. Pure RNA samples were analyzed by
quantitative RT-real-time PCR with HIV-1 speciﬁc primers. (A) HIV-1 provirus counts in blood cells of infected animals, 10 days post-IR. The cellular fraction was isolated from
0.5 ml blood samples; total DNA was puriﬁed and subjected to real-time PCR with R-U5 LTR-speciﬁc primers to detect HIV-1 DNA. Results are shown as a mean of three
independent measurements7SD. (B) Viral RNA in the blood samples of animals – 28 days before and 10 days after IR. The total puriﬁed RNA was subjected to quantitative
RT-PCR with gag-speciﬁc primers. Results are shown as a mean of three independent measurements7SD. Asterisks indicate pr0.01 between RNA samples from the same
animal before and after IR. (C) The HIV-1 RNA/DNA ratio in the blood of infected animals, 10 days post-IR. Total RNA and DNA were puriﬁed as in panels A and B, and then
subjected to RT-qPCR with (RNA) or qPCR (DNA) with gag-speciﬁc primers. Results are shown as a mean of three independent measurements7SD. Asterisks indicate
pr0.01 between samples from the same animal before and after IR. (D) The total RNA extracted from indicated organs at day 10 after IR was subjected to HIV-1 RNA
quantitation using qRT-PCR as described in (B). Results are shown as a mean of three independent measurements7SD. The dash line indicates the cutoff level of HIV-1 RNA.
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ratio of unspliced viral RNA and viral DNA in the total pellet of
blood cells displayed from 7 to 100 fold increase of HIV-1 RNA
proportion within 10 days after IR (Fig. 5C). The qPCR of the RNA
isolated from the blood cells, liver, lung, brain and spleen of the
mice sacriﬁced on day 10 after IR revealed various detectable
levels of viral RNA. The RNA levels in lung and brain specimens
were similar to the levels in blood cells, whereas the liver and
spleen tissues showed lower levels of viral RNA (Fig. 5D). Finally, to
test toxicity of IR for the mice, we performed analysis of the
viability of other group of mice within 90 days after exposure to
doses 1.0, 2.5, 5.0, 7.5 and 10.0 Gy of X-ray IR. We found that
7.5 and 10 Gy doses of IR resulted in death of the mice in 6 and
9 days post IR, whereas the mice subjected to 5 Gy and lower IR
doses did not die during the whole period of observation (data not
shown).
To model latent HIV-1 infection in the humanized mice, new
set of mice infected with dual-tropic 89.6 virus were then injected
intraperitoneally three times with the cocktail of four antiretrovir-
als in weeks 8, 9 and 10 after infection. Quantitative RT-PCR
analysis of whole blood samples indicated rather high amount of
viral RNA (from 1500 to 16,000 copies per 0.2 ml sample as shown
in Fig. 6A, right panel) within two months post-infection. Dramatic
reduction of HIV-1 RNA to very low level (from 45 to 600 copies
per 0.2 ml sample) was detected in the blood of ART-treated mice
as compared with the same animals before treatment (from 4000
to 17,000 copies/sample), whereas the count of viral DNA in the
lysates of total blood cells was reduced by an average of 4.6 times
(Fig. 6A, middle panel). Exposure of the ART-treated mice to two
1 Gy doses of IR on the 7th and 9th days after last ART injection
resulted in 20–1000-fold increase of viral RNA count in the blood
on day 2 after second X-ray IR exposure (Fig. 6A, right panel). The
count of viral DNA has also been approximately ﬁvefold increased
probably due to the reverse transcription and accumulation of
cDNA in newly infected cells. It is important to note that the count
of human β globin DNA (marker of human cells) was not
signiﬁcantly changed within the whole time of experiment
(Fig. 6A, left panel) Analysis of the ratio of unspliced viral RNA to
viral DNA in the total blood samples showed that HIV-1 infected
females (Fig. 6B, # 603–605) demonstrated higher level of viral
RNA transcription prior to ART treatment, but relatively low
increase after post-ART irradiation (5–30 ) which is lower than
the RNA level prior to ART treatment. Whereas the males dis-
played relatively low initial level of HIV-1 transcription, but in 50%
cases showed dramatic increase of the viral transcription after IR:
the RNA level after IR was the same (#606, 609, and 610) or 10-
fold higher (#607, 608, and 611) compared to pre-ART RNA count.
These data suggest that the HIV-1 infected females had initially
higher level of virus transcription, probably due to better engraft-
ment of human CD34þ cells than in NSG males as reported earlier
(Denton and Garcia, 2011; Martin-Padura et al., 2010; Notta et al.,
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Fig. 6. IR doses induce viral transcription in ART-treated latently HIV-1 infected humanized mice. Nine NSG humanized mice were infected with dual-tropic HIV-1 89.6
strain and two mice were left as an uninfected control. The infected and uninfected mice were injected i.p. three times with ART cocktail in week 8, 9 and 10 after infection
time point. The mice were then irradiated with double 1 Gy doses of X-ray on days 7th and 9th after last ART injection. The 0.2 ml specimens of blood were collected before
(Untreated), after ART treatment (ART) and 48 h after second IR (IR, post-ART). (A) Statistical analysis of HIV-1 response to ART treatment and IR in the blood samples from
9 infected animals. Total RNA and DNA was puriﬁed from the blood specimens and then subjected to RT-qPCR with oligo-dT and gag primers (RNA) to measure count of
unspliced viral RNA, and to qPCR with human β globin and HIV-1 gag primers (DNA) to measure human and viral DNA count, respectively. Asterisk shows p valuer0.05
between the samples connected by bracket. (B) The HIV-1 RNA/DNA ratio in the blood specimens of infected and control uninfected mice, 2 days post-second IR. Total RNA
and DNA were puriﬁed and subjected to RT-qPCR and qPCR with HIV-1 gag-speciﬁc primers as described in panel A. Results are shown as a mean of three independent
measurements7SD. Asterisks indicate pr0.01 between RNA/DNA count in indicated samples (IR post-ART) and RNA/DNA count in the samples collected after ART from the
same animal.
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2010). Taken together, our results indicate that IR signiﬁcantly
activates HIV-1 expression in the blood and some tissue reservoirs
including brain and lung of the infected humanized mice.
Discussion
Despite the wide use of IR for therapy for different types of
cancers and application of the whole body IR used for HIV-1
infected individual known as “Berlin patient“ for destruction of his
lymphoma prior to CCR5Δ32/Δ32 donor hematopoietic stem cell
transplantation, the effect of therapeutic doses of IR on HIV-1 has
not been fully recognized. Meanwhile, the total body IR treatment
with the doses of 2 Gy and 4 Gy (Allers et al., 2011) that were
applied to Berlin patient prior to the transplantation did not have
documented negative effect on other tissues (Yukl et al., 2013).
Importantly, the virus was likely eradicated from latent reservoirs,
since further prolonged tests could not detect HIV-1 in PBMCs,
spinal ﬂuid, lymph node, or terminal ileum, and no replication-
competent virus could be cultured from PBMCs (Yukl et al., 2013).
Therefore, these data point to the importance of studying the
impact of IR treatment on HIV-1 replication, speciﬁcally within the
context of reactivation and depletion of the latent viral reservoirs.
Our data presented above indicated that a single dose of X-ray
IR activated HIV-1 replication in both chronically infected lym-
phoblastoid and monocytic cell lines as well as in CD4þ resting T
cells. We found that IR treatment of cells correlated with dissocia-
tion of the histone deacetylase HDAC1, and methyl transferase
SUV39H1 from the HIV-1 LTR promoter. Direct involvement of
these factors in HIV-1 latency was shown previously by a number
of colleagues (Pearson et al., 2008; Tyagi et al., 2010). Our data
further suggest a triggering effect of IR on HIV-1 transcription via
epigenetic mechanisms. In fact, the studies of the last decade
revealed involvement of various epigenetic factors in IR stress-
induced transcription activation associated with DNA damage
response. In IR-sensitive tumor cells, the γ-IR has been shown to
induce the global demethylation of various promoter sequences
(Kumar et al., 2011). Inhibitory effect of IR-induced DNA damage
on HDAC1 followed by transcriptional activation was shown for
both cellular and viral promoters such as HBV (Chung and Tsai,
2009; Peng et al., 2007). At the same time, typical for IR response
activation of NHEJ pathway to repair DNA double-strand breaks
leads to activation of the homologous HATs, including CBP and
p300 factors (Ogiwara et al., 2011). The CBP/p300 proteins are
recruited to the sites of doublestrand brakes and contribute to
acetylation of lysine 18 within histone H3, and lysines 5, 8, 12, and
16 within histone H4. This also correlates with the recruitment of
BRM, a catalytic subunit of the SWI/SNF complex involved in
chromatin remodeling (Agbottah et al., 2006; Ogiwara et al., 2011;
Van Duyne et al., 2011). Together, these published data indicate
important role of epigenetic events such as inhibition of promoter
methylation and enhancement of histone acetylation in the
cellular response to IR-induced DNA damage. Since acetylation of
LTR-bound nucleosomes by HATs is involved in activation of HIV-1
transcription (Deng et al., 2000, 2001), inhibition of HDACs is
critical for LTR transcription and important for reactivation of
latent HIV-1 provirus (Archin et al., 2009, 2012; Blazkova et al.,
2012; Quivy et al., 2002; Van Lint et al., 1996).
Our data that the irradiation of HIV-1 infected cells enhanced
level of apoptosis in the irradiated cells suggest that activation of
HIV-1 replication in response to IR can trigger apoptotic pathways
likely via the potential effect of HIV-1 Tat on p53 phosphorylation
(Kim et al., 2010). In fact, we have observed presence of Tat after IR
when transfecting an epi-Tat construct into lymphocytes (CEM)
following IP/WB for presence of Tat after 48 h (data not shown).
IR-induced p53 phosphorylation at Ser15 and Ser20 are utilized for
DNA repair and release, whereas Ser46 phosphorylation is critical
for apoptosis (Haas, 2009; Shahbazi et al., 2013; Yamaguchi et al.,
2001). Western blot analysis of chronically-HIV-1 infected T cell
line and parental uninfected cells revealed involvement of the
mechanism of p53-dependent apoptosis in both infected and
uninfected irradiated cells, with the level of phosphorylation of
Ser46 residue markedly higher on the p53 protein from infected
cells. This may potentially explain lower viability of HIV-1 infected
cells after IR. Since Tat has been shown to activate PKCδ in HIV-1
infected cells (Bennasser and Bahraoui, 2002; Leghmari et al.,
2008a, 2008b), this interaction might facilitate p53-dependent
apoptosis in response to IR induced HIV-1 activation. Moreover, it
has also been found that Tat protein binds directly to p53 and
hence down-regulates p53-dependent transcription (Harrod et al.,
2003; Li et al., 1995; Longo et al., 1995) and therefore IR-induced
Tat expression may potentially deregulate p53-mediated DNA
repair (Fig. 7A). Other recently published data indicate that the
apoptosis induced in ACH-2 and U1 cells by such cytotoxic agents
as doxorubicin, etoposide, ﬂudarabine phosphate, or vincristine
signiﬁcantly activated latent HIV-1 infection and resulted in
increased level of coding viral RNA and p24 production (Khan
et al., 2015). This suggests that along with induction of p53-
dependent apoptosis in response to IR-activated HIV-1 expression,
the IR stress-induced apoptosis in turn may enhance HIV-1
transcription and replication.
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Fig. 7. Summarized data of the effect of X-ray irradiation on the cell viability
and virus transcription in HIV-1 infected cells. (A) IR-induced DNA damage in
HIV-1 infected and uninfected cells mediates phosphorylation of various Ser
residues on p53 protein resulting in DNA repair or apoptosis (adapted from
Shahbazi et al. (2013) with modiﬁcations). Low IR doses cause DNA damage that
activates p53 via phosphorylation of Ser9, Ser15 and Ser46 on p53 in uninfected
cells as shown in Fig. 4B. Phosphorylated p53 activates p21WAF1 and p53-
dependent ribonucleotide reductase p53R2 which induce G1 arrest and DNA repair
pathway, respectively. IR of HIV-1 infected cells activates production of Tat and viral
accessory proteins which cause up-regulation of DNA damage machinery (Kim
et al., 2012; Koyama et al., 2013). Tat can also activate PKCδ (Bennasser and
Bahraoui, 2002; Leghmari et al., 2008a, 2008b) that induces enhanced phosphor-
ylation of Ser46 on p53 which results in p53-dependent apoptosis. (B) Consolidated
data on the effect of IR and IR with latency-reversing agent bryostatin 1 on HIV-1
transcription in latently infected T cells and monocytes.
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A number of colleagues have previously shown that HIV-1
replication induces apoptosis via p53-independent pathways
(Bartz and Emerman, 1999; Ferri et al., 2000; Jacotot et al., 2000;
Rasola et al., 2001; Sastry et al., 1996; Stewart et al., 2000; Terai
et al., 1991). Since IR is able to activate expression of HIV-1
genome, viral proteins such as Env, Tat, Vpr, Vpu, Nef, and Vif
whose pro-apoptotic activity is well described (reviewed in
Cossarizza (2008)), may activate apoptosis in the IR treated cells.
Moreover, earlier studies have also shown that IR itself might
induce the same mechanism of apoptosis as viral Vpr protein,
which involves the Wee-1 kinase depletion (Yuan et al., 2003).
Modulators of PKC activity, such as PMA and prostratin were
earlier investigated for their capacity to reactivate latent HIV-1 in
T-lymphocytes and monocyte/macrophages (Biancotto et al.,
2004; Brooks et al., 2003; Trushin et al., 2005). PKC signaling
may activate transcription of the latent HIV-1 provirus via recruit-
ment of cellular transcription factors such as NF-κB, NF-AT and
AP1 (Beans et al., 2013; Williams et al., 2004). Bryostatin 1, like
prostratin also targets PKC but it is signiﬁcantly more potent
(DeChristopher et al., 2012). In our experiments we observed
enhancement of bryostain 1-induced HIV-1 reactivation in
latently-infected monocytes by single IR doses of 1 and 3 Gy. Since
low doses of bryostatin 1 have been shown to be capable of
activating PKCδ (Mehla et al., 2010), we hypothesize that IR-
induced expression of Tat could strengthen impact of bryostatin
1 via additional activation of PKCδ by Tat protein (as previously
described (Bennasser and Bahraoui, 2002; Leghmari et al., 2008a,
2008b)). Summarized data on the effect of IR and bryostatin
1 treatment on the latently HIV-1 infected T cells and monocytes
are shown in Fig. 7B. Taken together, our results indicate that low
doses of IR had a moderate effect on HIV-1 reactivation in latently-
infected CD4þ T cells, but affected the infection dramatically in
monocytes/macrophages, especially when IR was in combination
with bryostatin 1 treatment.
Our experiments with the model of humanized mice, where
the basal level of virus replication was virtually undetectable
either after six months of infection or after triplicate injection of
antiretrovirals, indicated that single dose of IR (4 Gy) or double
1 Gy dose could activate HIV-1 transcription in peripheral blood
cells as well as in the lung and brain tissues. This observation is
especially interesting since both brain and lung tissues are rich in
macrophages, including alveolar and microglia (Eilbott et al., 1989;
Pollard, 2009; Wiley et al., 1986). It is also important to note that
blood was not removed from these organs prior to RNA isolation,
which may contribute to presence of viral RNA in these samples.
Finally, potent effect of IR on latently HIV-1 infected monocytes
after PKC activation with bryostatin 1, transferring these cells to
macrophage phenotype, may explain observed dramatic reactiva-
tion of HIV-1 transcription in macrophage-rich tissues in the mice
after IR.
Conclusions
Collectively, our results demonstrate activating effect of ther-
apeutic doses of X-ray IR on HIV-1 LTR-driven transcription and
viral replication in major HIV-1 host cells, and increased apoptosis
in HIV-1 infected T cells. Use of low doses of IR (less than 0.5 Gy) in
combination with chemical agents leading to reactivation of HIV-1
transcription, such as HDAC inhibitors (SAHA, vorinostat) or PKC
modulators like prostratin or bryostatin 1, holds great promise for
reactivation of latent HIV-1 in reservoirs in vivo. Unlike the
chemical compounds, IR affects various tissues independently of
their location in the body and does not have the complication of
delivery into various body compartments. Thus, our data suggest
an alternative strategy to activate and eradicate HIV-1 from
persistently infected reservoirs to subsequently eliminate the
activated virus using traditional therapeutic approaches. Future
experiments will better deﬁne the possible combination use of IR
and other agents for the “shock and kill” strategy.
Materials and methods
Cells and viruses
The human acute T leukemia lymphoblastoid cell line CCRF-
CEM was purchased from ATCC (Manassas, VA). Chronically HIV-1
infected U-937 subclone U1 and CEM subclone ACH-2 (Folks et al.,
1987; Perez et al., 1991) were provided by the NIH AIDS Research &
Reference Reagent Program. All cells were maintained at 37 1C and
5% CO2 in 25 cm2 and 75 cm2 tissue culture ﬂasks with RPMI-1640
culture media supplemented with 10% Fetal Bovine Serum, peni-
cillin/streptomycin (100 μg/ml), and L-Glutamine (lymphoid and
myeloid cells). To reduce basic level of HIV-1 replication and
exclude reinfection, the chronically HIV-1 infected cells were
incubated for 7–10 days with the cocktail of three antiretrovirals
(lamivudine/emtricitabine, tenofovir and indinavir, each in con-
centration 10 mM) provided by NIH AIDS Research & Reference
Reagent Program. Then the cells were washed with PBS and
cultured in regular medium for 16–18 h until IR exposure. Periph-
eral blood mononuclear cells (PBMCs) were isolated from periph-
eral blood from healthy, anonymous donors using Ficoll gradient
centrifugation and then expanded in medium containing 1 mg/ml
PHA-L and 30 or 50 IU/mL rhIL-2. After two days of cultivation the
cells were washed and then cultured in the medium containing
30 IU/mL rhIL-2 without PHA-L.
The stocks of NL4-3BalEnv R5 virus or HIV-1 89.6 dual-tropic
strain (Collman et al., 1992) (provided by Dr. Ronald Collman via
NIH AIDS Research & Reference Reagent Program) were used for
infection of PHA-activated PBMCs (800 ng of p24 for 40106 cells/
ml). Cells were incubated with virus for 4 h and after washes, the
cells were cultured in complete RPMI 1640 medium supplemented
with 50 U/ml rhIL-2 (30 U/ml) for 10 days, treated with 1 ng/ml IL-7
and then cultured for 45 days to place the cells in quiescent phase.
CD 4þ T lymphocytes and latent infection with HIV-1
Primary cells latently infected with HIV-1 were generated
essentially as described in Marini et al. (2008), with some
modiﬁcations. Total CD4þ T cells were enriched by negative
selection with the CD4þ T Cell Isolation Kit (Miltenyi Biotec) from
PBMC of healthy seronegative donors. CD4þ T cells were activated
with monocyte-derived dendritic cells (MDDC; 1 MDDC:10 CD4þ
T cells), 500 ng/ml SEB and 50 U/ml IL-2. After 4 days half of the
cells were infected with a full length, replication competent HIV-1
strain expressing GFP (Brown et al., 2006) by spinoculation at
1200g for 2 h at room temperature. The other half of the cells was
left uninfected. Infected and uninfected cultures were expanded
for 10–15 days in medium containing 50 U/ml IL-2. When the
infected culture contained 10–15% infected cells as determined by
GFP positivity in ﬂow cytometry, both infected and uninfected
cultures were placed in quiescent phase for 7 days in medium
containing 1 ng/ml IL-7. At the end of the 7 day incubation, the
cultures were irradiated and then cultured for 96 h.
Flow cytometry
Analysis of live/dead cells after irradiation was performed with
the Annexin V Apoptosis Detection Kit I from BD Biosciences
following the manufacturer's instructions. Brieﬂy, cells were har-
vested, washed with PBS and resuspended at 1106/ml in 1
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Annexin V Binding Buffer. Annexin V (5 ml/100 ml of cell suspension)
was added to each sample, followed by incubation for 15 min at
room temperature. Finally, an equal volume of 1 Annexin V
Binding Buffer was added, and the samples were analyzed by ﬂow
cytometry within 1 h using a FACScalibur and the software CellQuest
(BD Biosciences). Surface staining of CD4 and CXCR4 receptors
exposed on the plasma membrane of CEM and ACH-2 cells was
performed with mouse monoclonal FITC-anti-human CD4 (BD
Pharmingen) and PE-anti-human CXCR4 (Biolegend). Flow cytome-
try ﬁles were analyzed using FlowJo (Tree Star, Ashland, OR).
Reverse transcriptase (RT) activity analysis
RT analyses were performed as published previously (Easley
et al., 2010). Brieﬂy, 10 ml of cell culture supernatants were
incubated in a 96-well plate with RT reaction mixture containing
1RT buffer (50 mM Tris–HCl, 1 mM DTT, 5 mM MgCl2, 20 mM
KCl, 0.1% Triton, poly-r(A) 1U/ml, oligo-d(T) 1 U/ml, and [3H] dTTP).
The mixture was incubated for 2 h at 37 1 C, and 5 ml of the
reaction mix was spotted on a DEAE Filtermat paper, washed four
times with 5% Na2HPO4 and four times with water, and dried.
RT activity was measured in a Betaplate counter (Wallac,
Gaithersburg, MD).
DNA isolation and quantitative real-time PCR
The cells from blood samples of the uninfected control and HIV-1
infected humanized mice were normalized to the total protein count
using DC Protein Assay (BioRad, Hercules, CA), lysed in the Nuclei
Lysis Solution (Promega, Madison, WI), and the total DNA was then
isolated from lysates using Wizard Genomic DNA Puriﬁcation Kit
(Promega) according to manufacturer's protocol. After isolation, the
cellular DNA samples were analyzed by quantitative TaqMan real-
time PCR. The primers For-Late: 50-TGTGTGCCCGTCTGTTGTGT-30,
Rev-Late: 50-GAGTCCTGCGTCGAGAGATC-30, and probe 1312-Lt-LTR:
50-FAM-CAGTGGCGCCCGAACAGGGA-TAMRA-30, were used to recog-
nize the U5-Ψ HIV-1 LTR region. Set of primers speciﬁc for human β-
globin gene has been used to assess presence of human cells in the
mice blood samples: forward primer BGF1 (50-CAACCTCAAACAGA-
CACCATGG-30), reverse primer BGR1 (50-TCCACGTTCACCTTGCCC-30),
and probe BGX1 (50-FAM-CTCCTGAGGAGAAGTCTGCCGTTACTGCC-
TAMRA-30). PCR reactions were performed with PerfeCTa qPCR
FastMix, UNG (Quanta Biosciences, Gaithersburg, MD) using
300 nM of each primer and 200 nM of probe according to the
manufacturer's protocol. Serial dilutions of DNA from 8E5 cells (CEM
cell line containing a single copy of HIV-1 LAV provirus per cell)
were used as the quantitative standards. Real-time PCR reactions
were carried out at least in triplicate using the CFX96 Real-Time PCR
System (BioRad) and SFX Manager Software ver. 2.0.
RNA isolation and quantitative RT-PCR
For quantitative analysis of HIV-1 RNA, total RNA was isolated
from various samples including: PBMC lysates, lysates of primary
CD4þ T cells and chronically HIV-1 infected cell lines (ACH-2, U1),
blood specimens of HIV-1-infected humanized mice and homoge-
nized mice tissues (liver, lung, brain, and spleen). RNA was isolated
using Trizol Reagent (Invitrogen, Carlsbad, CA) according to the
manufacturer's protocol. A total of 0.5 μg of RNA from the RNA
fraction was treated with 0.25 mg/ml DNase I RNase-free (Roche,
Mannheim, Germany) for 60 min in the presence of 5 mM MgCl2,
followed by heat inactivation at 65 1 C for 15 min. A 200–250 ng
aliquot of total RNA was used to generate cDNA with the GoScript
Reverse Transcription System (Promega, Madison, WI) using TAR-
speciﬁc reverse primer TARﬂl-R: 50-GTGGGTTCCCTAGTTAGC-30 or
oligo-dT reverse primers. Subsequent quantitative real-time PCR
analysis was performed with 2 ml of undiluted and 10–1 and 10–2
diluted aliquots of RT reaction mixes. The iQ SYBR Green Supermix
(Bio-Rad, Hercules, CA) was used with the primers speciﬁc for (1)
HIV-1 TAR: TARﬂl-F: 50-GGTCTCTCTGGTTAGACC-30 and TARﬂl-R as
above ampliﬁed 60 nt. TAR sequence; (2) HIV-1 env gene: Env2019F:
50-GGCAAGTCTGTGGAATTGG-30 and Env2187R: 50-TGGGA-
TAAGGGTCTGAAACG-30 ampliﬁed 168 nt. fragment of HIV-1 env
and (3) HIV-1 gag gene: Gag1483-F (50-AAGGGGAAGTGACATAGCAG-
30) and Gag1625-R (50-GCTGGTAGGGCTATACATTCTTAC-30) amplify-
ing 143 nt. fragment of HIV-1 gag sequence. The quantitation of U5-
Ψ HIV-1 LTR sequences was performed by quantitative TaqMan real-
time PCR using PerfeCTa qPCR FastMix, UNG (Quanta Biosciences)
using the primers described in previous section. Real-time PCR
reactions were carried out at least in triplicate as described above.
X-ray irradiation and HIV-1 reactivation in cell cultures
The HIV-1 latently infected, treated or not with ART cocktail,
and control uninfected cells were plated onto 24-well or 12-well
plates in 1 or 1.5 ml of complete culture medium respectively.
After overnight incubation the cells were treated or not with
various concentrations of bryostatin 1 (Sigma-Aldrich, St. Louis,
MO) diluted in 1 PBS and then exposed to various doses of X-ray
irradiation using RS 2000 X-ray Irradiator (Rad Source, Suwanee,
GA). The cell cultures were then incubated for 24, 48 or 72 h for
virus activation.
Chromatin immunoprecipitation (ChIP) assay
Cell cultures were collected 48 h post-irradiation and then
processed for ChIP analysis. Approximately 5106 cells were used
for immunoprecipitation. ChIP assays were performed as pre-
viously described (Klase et al., 2007). Brieﬂy, cells were harvested,
washed with PBS, and resuspended in 1% formaldehyde for 10 min
at 37 1C. Then the cells were washed twice with PBS and
resuspended in 500 ml of SDS Lysis Buffer (1% SDS, 10 mM EDTA,
50 mM Tris–HCl, pH 8.1) per sample. Cells were sonicated for six
10 s pulses and clariﬁed by centrifugation at 14,000 rpm for
10 min at 4 1C. Supernatants were collected and diluted 10 fold
in ChIP dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA,
16.7 mM Tris–HCl, pH 8.1, 167 mM NaCl). Extracts were precleared
with ChIP prepared A/G beads (Protein A/G beads with 10 mg/mL
salmon sperm DNA and 10 mg/mL BSA) for 1 h at 4 1C. After
preincubation, the extracts were spun at 3000 rpm for 10 min at
4 1C and the supernatants were transferred to a new tube. Speciﬁc
antibodies (5 mg) were incubated overnight at 4 1C on a rotator.
ChIP prepared A/G beads were added the next day and allowed to
rotate for 2 h at 4 1C. Samples were spun for 5 min at 3000 rpm at
4 1C and washed successively with 1 low salt buffer (0.1%SDS, 1%
Triton X-100, 2 mM EDTA, 20 mM Tris–HCl, pH 8.1, 150 mM NaCl),
2 high salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA,
20 mM Tris–HCl, pH 8.1, 500 mM NaCl), 1 LiCl wash buffer
(0.25 M LiCl, 1% NP-40, 1% deoxycholate, 1 mM EDTA, 10 mM
Tris–HCl, pH 8.1), and 1 TE. Complexes were eluted off of beads
twice with elution buffer (1% SDS, 0.1 M NaHCO3). Eluates were
then reverse crosslinked using 5 M NaCl and 50 mg/mL proteinase
K for 5 h at 55 1C. DNA was extracted with phenol:chloroform,
precipitated with isopropanol, washed and resuspended in 50 ml of
TE buffer. Speciﬁc DNA sequences in the immunoprecipitates were
detected by PCR using primers speciﬁc for the HIV-1 LTR between
–92 to þ180 nt (forward primer, 50-ACTTTTCCGGGGAGGCGC-
GATC-30; reverse primer, 50-GCCACTGCTAGAGATTTCCACACTG-30)
(Zhou et al., 2003).
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SDS-PAGE and Western blot analysis
Proteins from total cell extracts were separated by SDS-PAGE
on 4–20% Tris–glycine gels (Invitrogen). For Western blot analyses,
proteins were transferred to PVDF membranes (BioRad) at 80 mA
for 4 h. Membranes were blocked with Dulbecco's phosphate-
buffered saline (PBS)þ0.1% tween-20þ5% dry milk for 1 h at room
temperature. Primary antibodies against speciﬁed proteins were
incubated with the membranes overnight at 4 1C. Anti-HIV-1 p24
Gag monoclonal antibody #24-3 (from Michael H. Malim) were
provided by the NIH AIDS Research & Reference Reagent Program.
Anti-PARP-1/2 (H-250) rabbit polyclonal antibody was from Santa
Cruz Biotechnology (Dallas, TX). For analysis of p53 phosphoryla-
tion, the rabbit polyclonal antibodies against S9-P, S15-P and S46-P
from P-p53 Ab Sampler Kit (Cell Signaling, Danvers, MA) were
used. Membranes were then washed twice with PBSþ0.1% tween-
20 and incubated with HRP-conjugated secondary antibody for 2 h
at 4 1C. Membranes were washed two times with PBSþ0.1%
Tween-20, and once with PBS prior to imaging. HRP luminescence
was elicited with Super Signal West Dura Extended Duration
Substrate (Pierce) and visualized by a Bio-Rad Molecular Imager
ChemiDoc XRS system (BioRad).
Cell viability assay
Cell viability was assessed using CellTiter-Glo Luminescent Cell
Viability Assay (Promega, Madison, WI, USA) following the manu-
facturer's recommendations. Brieﬂy, the reagent was added to the
wells of the 96-well plate with cells (1:1 reagent:media) and
incubated at room temperature for 10 min protected from light.
The luminescence signal was recorded using the GloMax-Multi
Detection System (Promega). The viable cell number was normalized
with control group and the results shown as relative cell viability.
Preparation and infection of humanized mice
The NSG mice were humanized as described earlier (Shultz
et al., 2005; Van Duyne et al., 2008, 2009). Brieﬂy, neonates were
injected intraperitoneally (i.p.) with 1106 fetal liver derived
CD34þ hematopoietic stem cells and were maintained for no less
than 16 weeks to allow cell differentiation. Animals exhibiting
signiﬁcant levels of engraftment, as measured by CD45þ and
CD4þ cells in the peripheral blood, were then infected i.p. with
100 μl of dual-tropic HIV-1 89.6 (3000 TCID). The levels of HIV-1
RNA in serum and HIV-1 provirus in the white blood cells were
tested at 8 weeks after inoculation using qRT-PCR with the
primers speciﬁc for HIV-1 gag and by qPCR with the R-U5 LTR-
speciﬁc primer set, as described above. The mice were kept for
6 months to ensure absence of any viral RNA in the serum (latent
animals) or i.p. injected with ART cocktail (emtricitabine 210 mg/
kg, tenofovir 210 mg/kg, raltegravir 60 mg/kg, and maraviroc
60 mg/kg (Denton et al., 2012; Neff et al., 2010)) three times with
intervals 5–7 days. Then the mice were irradiated with non-lethal
single dose of 4 Gy (Guo et al., 2009; Wang et al., 2013) or double
1 Gy doses of X-ray (on days 7th and 9th after last ART injection)
using RS 2000 X-ray Irradiator (Rad Source). The blood was
collected 48 h after second IR treatment. The animals were
sacriﬁced in 10 days after IR; the blood, liver, lung, brain and
spleen (0.25–0.75 cm3 grinded tissue) were collected for further
analyses. Reactivation of HIV-1 was assessed by qRT-PCR of
unspliced viral RNA with gag-speciﬁc primers in the blood and
lysates of homogenized tissue specimens from HIV-1 infected and
uninfected control mice. All mouse experiments were approved by
the George Mason University Institutional Animal Care and Use
Committee (IACUC).
Statistical analysis
Quantitative data were analyzed by two-way ANOVA (Origi-
nPro v. 8.0) and Student's t test (Microsoft Excel; OriginPro).
Standard deviation was calculated in all quantitative experiments
for at least three independent preparations. The difference was
considered to be statistically signiﬁcant when pr0.05.
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